Be a part of the dynamic and critical field of microbiome drug development. Discover how drug developers are advancing their understanding of the role of the microbiome in disease and harnessing functionally relevant microbes for live biotherapeutic approaches.

With cutting-edge science, preclinical and clinical trial data, the 8th Microbiome Movement Drug Development Summit brought together pioneering drug developers and technology enablers to move the needle forward on microbial-based drug development innovation and healthcare industry adoption.

We explored critical areas of research, propel your business forward, and connected with industry leaders through interactive sessions such as discussion-based workshops, roundtables, panel discussions, Q&As, and speed networking. With three tracks - Discovery, Pre-clinical & Translation, and Clinical & Manufacturing - we discovered innovative new content for 2023 from leveraging the fungal and viral components of the microbiome, tuning the microbiome using bacterial engineering, exploring medical foods, and securing capital to scale your biotech business.

You've missed the 2023 opportunity to launch ground-breaking therapies into the market, but make sure to be a part of this exciting time in microbiome drug development for 2024 for registering your interest here.